Question 1

Am I eligible to participate in this study based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Real World Study of Lolatinib for Advanced ALK+ NSCLC Patients clinical trial (NCT06361589). Contact the study team or your healthcare provider for specific answers.

Question 2

How does lorlatinib compare to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Real World Study of Lolatinib for Advanced ALK+ NSCLC Patients clinical trial (NCT06361589). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of lorlatinib, and how will they be monitored?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Real World Study of Lolatinib for Advanced ALK+ NSCLC Patients clinical trial (NCT06361589). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Real World Study of Lolatinib for Advanced ALK+ NSCLC Patients clinical trial (NCT06361589). Contact the study team or your healthcare provider for specific answers.

Question 5

What kind of tests will be required during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Real World Study of Lolatinib for Advanced ALK+ NSCLC Patients clinical trial (NCT06361589). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects or my condition worsens during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Real World Study of Lolatinib for Advanced ALK+ NSCLC Patients clinical trial (NCT06361589). Contact the study team or your healthcare provider for specific answers.

What this study is about